NeoPharm CO. vs AUX: Fair Value & Quality
Both stocks run through our valuation models. Here is how NeoPharm CO. (092730) and AUX (AUX) compare, as of Sep 14, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
NeoPharm CO. leads: 9 to 1 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | NeoPharm CO.Price KRW 21,600 | AUXPrice PLN 1.18 |
|---|---|---|
| DCF Models | ▲+98%above the priceKRW 42,724 | ▼-68%below the pricePLN 0.38 |
| Earnings-Based | ●+9%close to the priceKRW 23,480 | ▼-81%below the pricePLN 0.23 |
| Multiples | ▲+35%above the priceKRW 29,247 | ▼-64%below the pricePLN 0.43 |
| Asset-Based | ▼-61%below the priceKRW 8,368 | ▼-60%below the pricePLN 0.47 |
| Growth DCF | ▲+62%above the priceKRW 35,001 | ▼-73%below the pricePLN 0.32 |
| Economic Profit | ●-5%close to the priceKRW 20,625 | ▼-69%below the pricePLN 0.36 |
| Growth Earnings | ▲+66%above the priceKRW 35,793 | ▼-75%below the pricePLN 0.29 |
| Minimum | ▼-61%below the priceKRW 8,368 | ▼-81%below the pricePLN 0.23 |
| Maximum | ▲+98%above the priceKRW 42,724 | ▼-60%below the pricePLN 0.47 |
| Median | ▲+35%above the priceKRW 29,247 | ▼-69%below the pricePLN 0.36 |
| Geometric mean | ▲+16%above the priceKRW 25,138 | ▼-71%below the pricePLN 0.34 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
NeoPharm CO.: 5 of 24 models see the stock below the current price.
AUX: 22 of 22 models see the stock below the current price.
Scenario ranges
From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
NeoPharm CO. · Consumer Staples
AUX · Consumer Staples
Bottom line
As of Sep 14, 2026, Fair Value Calculator sees NeoPharm CO. as the more attractively valued of the two: NeoPharm CO. trades at KRW 21,600 versus a fair value of KRW 35,793 (+66%), while AUX trades at PLN 1.18 versus PLN 0.39 (-67%).
NeoPharm CO. has the higher quality score (67/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.